The following message was updated on 5/16/2021 11:02:16 PM.
Rosol on Twitter..on P1 clinical study being conducted at @UCSDHealth on tilmanocept used as an imaging agent to evaluate the kidneys mesangial cells, as a biomarker for diabetic nephropathy...Broad Reach...Robust Pipeline
The expansion of mesangial cells is an early hallmark of #diabeticnephropathy, & the ability to reliably image them noninvasively could provide an important tool for physicians to evaluate diabetic patients for early signs of the disease. Learn more: https://bit.ly/3bf3ZnF$NAVB
#DYK: The worldwide prevalence of diabetes is expected to increase to 642 million within two decades. Approx. 40% of people with #diabetes will go on to develop diabetic nephropathy (“DN”) – a form of #ChronicKidneyDisease (“CKD”)